 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| AMG 786 / Amgen
Trial completion, Trial completion date, Trial primary completion date: Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity (clinicaltrials.gov) - Jun 10, 2024
P1, N=65, Completed, Sponsor: Amgen
Recruiting --> Completed | Trial completion date: Jun 2024 --> Aug 2023 | Trial primary completion date: Jun 2024 --> Aug 2023
- || AMG 786 / Amgen
Trial completion date, Trial primary completion date: Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity (clinicaltrials.gov) - Apr 10, 2023
P1, N=72, Recruiting, Sponsor: Amgen
Recruiting --> Completed | Trial completion date: Jun 2024 --> Aug 2023 | Trial primary completion date: Jun 2024 --> Aug 2023 Trial completion date: Oct 2023 --> May 2024 | Trial primary completion date: Oct 2023 --> May 2024
- ||| AMG 786 / Amgen
Enrollment open: Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity (clinicaltrials.gov) - Jul 27, 2022
P1, N=78, Recruiting, Sponsor: Amgen
Trial completion date: Oct 2023 --> May 2024 | Trial primary completion date: Oct 2023 --> May 2024 Not yet recruiting --> Recruiting
- ||| AMG 786 / Amgen
New P1 trial: Single and Multiple Ascending Dose Study to Evaluate AMG 786 in Healthy Participants and Participants With Obesity (clinicaltrials.gov) - Jun 5, 2022
P1, N=78, Not yet recruiting, Sponsor: Amgen